BRUKINSA®
Capsule
registration number
58/26/0130
What BRUKINSA® contains
Each capsule contains 80 mg zanubrutinib.
other ingredients
Ammonium hydroxide (trace), colloidal silicon dioxide, croscarmellose sodium, dehydrated ethanol (trace), gelatin, iron oxide black (trace), isopropyl alcohol (trace), magnesium stearate, microcrystalline cellulose, n-butyl alcohol (trace), propylene glycol (trace), purified water (trace), shellac glaze in ethanol (trace), sodium lauryl sulphate, titanium dioxide.
Therapeutic classification
Antineoplastic agents, Bruton’s tyrosine kinase inhibitors: L01EL03.